liver disease
Information
- Disease name
- liver disease
- Disease ID
- DOID:409
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00804583 | Active, not recruiting | Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease | March 2004 | July 2024 | |
| NCT02382822 | Active, not recruiting | Copenhagen Co-morbidity in HIV Infection Study | March 2015 | March 2025 | |
| NCT01425567 | Approved for marketing | Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury | |||
| NCT00058890 | Completed | Phase 3 | Gabapentin to Treat Itch in Patients With Liver Disease | November 2000 | January 2004 |
| NCT00063648 | Completed | Phase 1 | Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant | May 2002 | December 2007 |
| NCT00074386 | Completed | Kidney and Liver Transplantation in People With HIV | October 2003 | August 2013 | |
| NCT00078403 | Completed | Phase 2 | Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) | July 2004 | February 2009 |
| NCT00105235 | Completed | Phase 2 | Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients | June 2005 | March 2011 |
| NCT00162058 | Completed | Phase 2 | A Phase II Study of DMP 115 to Assess Focal Liver Lesions | March 2004 | April 2006 |
| NCT04883177 | Completed | Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101) | May 11, 2021 | May 1, 2022 | |
| NCT00005657 | Completed | Genetics of Hepatitis C Virus Infection | May 4, 2000 | April 19, 2011 | |
| NCT00006062 | Completed | Phase 1 | Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction | July 2000 | May 2001 |
| NCT00887887 | Completed | The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery | January 2008 | January 2014 | |
| NCT00975702 | Completed | Phase 3 | Remote Ischemic Preconditioning In Abdominal Organ Transplantation | April 2009 | June 2014 |
| NCT01030484 | Completed | Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2 | December 2, 2009 | May 31, 2020 | |
| NCT01046799 | Completed | Phase 3 | Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir | March 2008 | October 2014 |
| NCT01061684 | Completed | NAFLD Pediatric Database 2 | January 20, 2010 | May 31, 2020 | |
| NCT01081210 | Completed | Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound | March 2010 | October 2010 | |
| NCT01187186 | Completed | Phase 1 | A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941 | May 2010 | August 2010 |
| NCT01303549 | Completed | Phase 4 | Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients | November 2011 | May 2014 |
| NCT01316679 | Completed | An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 | March 2011 | January 2013 | |
| NCT01324349 | Completed | N/A | Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery | February 2011 | September 2011 |
| NCT01331187 | Completed | N/A | Influence of Routinely Adding Ultrasound Screening in Medical Department | April 1, 2011 | June 2011 |
| NCT01370148 | Completed | Phase 1 | A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan | April 2011 | February 2014 |
| NCT01407666 | Completed | N/A | Comparison Between Epidural and Bilateral Paravertebral Blocks in Liver Resection | August 2010 | November 2014 |
| NCT01437969 | Completed | Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment. | September 2011 | September 2022 | |
| NCT01650181 | Completed | Phase 4 | Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis | November 2011 | June 2014 |
| NCT01761851 | Completed | Resting Energy Expenditure in Patients on the Waiting List for Liver Transplantation | March 2010 | December 2011 | |
| NCT01764581 | Completed | N/A | Randomized Controlled Trial of ImmuKnow in Liver Transplantation | July 2008 | March 2012 |
| NCT01789008 | Completed | N/A | Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease. | February 2013 | August 18, 2017 |
| NCT01867385 | Completed | The Physiology of Fatigue in Patients With Chronic Liver Disease | May 31, 2013 | November 20, 2018 | |
| NCT01958190 | Completed | Phase 4 | Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus | February 7, 2011 | May 20, 2021 |
| NCT01968395 | Completed | Phase 4 | Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure | September 2013 | October 21, 2014 |
| NCT01970904 | Completed | N/A | Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients | October 2013 | March 2015 |
| NCT01988753 | Completed | Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases | October 2013 | June 2016 | |
| NCT02010034 | Completed | N/A | Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury | August 2013 | February 5, 2019 |
| NCT02046473 | Completed | N/A | 3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts | July 2013 | April 2015 |
| NCT02094443 | Completed | Phase 2 | Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option | March 2014 | April 2015 |
| NCT02139722 | Completed | N/A | Patient-Centered Care and Asian Americans | January 2, 2014 | July 30, 2017 |
| NCT02209675 | Completed | N/A | Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation | December 2012 | October 2014 |
| NCT02306018 | Completed | Evaluation of EV1000™/volumeView™ for Cardiac Output Monitoring in Liver Transplantation | October 2014 | September 2015 | |
| NCT02311348 | Completed | Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy | November 20, 2014 | December 21, 2016 | |
| NCT02329821 | Completed | Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection | November 2014 | June 2015 | |
| NCT02366845 | Completed | Phase 4 | Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease | June 27, 2012 | March 27, 2019 |
| NCT02506335 | Completed | Early Phase 1 | Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease | September 1, 2015 | May 1, 2018 |
| NCT02520609 | Completed | Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease | October 28, 2015 | May 14, 2020 | |
| NCT02523196 | Completed | Phase 3 | Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG) | March 2016 | February 23, 2017 |
| NCT02684526 | Completed | N/A | Is Eovist Suitable for Arterial-Phase MR Imaging of Liver | December 2011 | October 2016 |
| NCT02798861 | Completed | Controlled Attenuation Parameter (CAP) in Liver Allografts | September 7, 2016 | June 1, 2019 | |
| NCT02938013 | Completed | Phase 4 | deLIVER: Direct Acting Antiviral Effects on the Liver | January 2017 | September 30, 2020 |
| NCT02947594 | Completed | Half-life of Plasma Phytosterols in Very Low Birth Weight Preterm Infants With Parenteral Nutrition-associated Cholestasis | January 2014 | February 2017 | |
| NCT03563404 | Completed | Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation | June 29, 2015 | June 29, 2016 | |
| NCT03600714 | Completed | Phase 2 | Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon | August 1, 2018 | August 11, 2020 |
| NCT03765671 | Completed | Phase 1 | Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients | December 12, 2018 | June 14, 2019 |
| NCT03814005 | Completed | Phase 1 | A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems | July 10, 2019 | April 19, 2022 |
| NCT04185454 | Completed | N/A | Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese | September 1, 2018 | April 15, 2019 |
| NCT04408937 | Completed | Phase 1 | The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor. | May 29, 2020 | November 4, 2020 |
| NCT00001719 | Completed | Magnetic Resonance Imaging of Blood Flow in the Liver and Abdomen | August 1998 | August 2002 | |
| NCT00206076 | Completed | Phase 4 | Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation | August 2006 | June 2009 |
| NCT00229580 | Completed | Phase 1 | Health Behavior Feedback Study for Veterans With Hepatitis C | December 2003 | January 2006 |
| NCT00245830 | Completed | N/A | Ischemic Preconditioning of Liver in Cadaver Donors | October 2003 | March 2007 |
| NCT00621881 | Completed | Phase 1 | A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects | January 2008 | |
| NCT00655707 | Completed | Phase 1/Phase 2 | A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency | January 2006 | April 2009 |
| NCT00657124 | Completed | Phase 4 | Effect of Preoperative Supplementation in Insulin Resistance | April 2007 | December 2007 |
| NCT00677625 | Completed | Pediatric Liver Database | June 2003 | September 15, 2016 | |
| NCT00799851 | Completed | Phase 4 | A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices | November 2004 | August 2007 |
| NCT00829231 | Completed | Phase 1 | Hepatic Impairment Study | January 2009 | July 2009 |
| NCT00839709 | Completed | Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols | March 2009 | February 2011 | |
| NCT00851227 | Completed | Phase 1 | Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function | February 2009 | January 2010 |
| NCT00874224 | Completed | N/A | Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery. | January 2010 | July 2014 |
| NCT00883454 | Completed | Estimation of Functional Liver Reserve Using Cholinesterases | |||
| NCT02477345 | No longer available | Compassionate Use of Omegaven IV Fat Emulsion | |||
| NCT00492739 | Recruiting | Phase 2/Phase 3 | Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients | June 2007 | December 2025 |
| NCT02322073 | Recruiting | Inflammation and Obesity-associated Disease | December 1, 2014 | December 2025 | |
| NCT00001971 | Recruiting | Evaluation of Patients With Liver Disease | May 27, 1992 | ||
| NCT04014413 | Recruiting | N/A | Safety and Efficacy of Fecal Microbiota Transplantation | July 15, 2019 | October 31, 2030 |
| NCT01810640 | Terminated | N/A | Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors | February 2013 | February 2015 |
| NCT00271245 | Terminated | N/A | Selenium Supplementation of Patients With Cirrhosis | February 2006 | March 2012 |
| NCT00550849 | Terminated | Phase 1/Phase 2 | Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction | April 30, 2007 | November 30, 2007 |
| NCT00588146 | Terminated | Phase 2 | Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia | January 2007 | September 2011 |
| NCT00741117 | Terminated | N/A | Conjugated Hyperbilirubinemia and Pulse Oximetry | October 2011 | October 2011 |
| NCT00742326 | Terminated | Phase 4 | Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections | August 2008 | January 2013 |
| NCT00808990 | Terminated | Phase 1 | The Effect of Probiotics on Non Alcoholic Fatty Liver Disease | February 2013 | September 2015 |
| NCT01031550 | Terminated | N/A | Isoflurane Preconditioning for Liver Resections | January 2010 | June 2012 |
| NCT02186054 | Terminated | N/A | T2 Weighted Imaging of the Liver With Fast Spin Echo MRI | June 2014 | June 2016 |
| NCT02201472 | Terminated | N/A | Magnetic Resonance Elastography in Infants | August 2014 | August 2015 |
| NCT02710266 | Terminated | Phase 3 | Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection | February 24, 2012 | February 25, 2017 |
| NCT00152607 | Terminated | Phase 4 | Orthotopic Liver Transplantation Using a Living Donor | April 2000 | September 2006 |
| NCT02717949 | Terminated | Phase 4 | Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study | February 25, 2016 | July 18, 2017 |
| NCT01483248 | Unknown status | Phase 1/Phase 2 | Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis | October 2010 | October 2015 |
| NCT01847612 | Unknown status | Phase 3 | Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy | July 8, 2013 | August 2018 |
| NCT00844779 | Unknown status | Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients | February 2009 | January 2011 | |
| NCT00564538 | Unknown status | Phase 4 | A Study of Thymoglobulin and Tacrolimus in Liver Transplant | December 2007 | December 2009 |
| NCT04116242 | Unknown status | MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease | August 27, 2015 | December 2022 | |
| NCT02873663 | Unknown status | N/A | Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease | December 2010 | August 2016 |
| NCT02696655 | Unknown status | N/A | Lifestyle Intervention For Liver Transplantation | February 2016 | February 2018 |
| NCT00155376 | Unknown status | Phase 4 | Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography | September 2005 | September 2005 |
| NCT00172705 | Unknown status | Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique | September 2004 | February 2005 | |
| NCT00852293 | Unknown status | The Connection Between Liver Disease and Chitinase Proteins | March 2009 | March 2014 | |
| NCT02452177 | Unknown status | N/A | Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver Disease | May 2015 | February 2016 |
| NCT02901119 | Unknown status | N/A | Effects of Whey Protein Consumption by Patients Waiting for Liver Transplantation | July 2014 | December 2018 |
| NCT00935454 | Unknown status | Phase 1 | Hepatocyte Matrix Implant Study | July 2009 | March 2012 |
| NCT02917382 | Unknown status | Evolution and Clinical Outcomes in Patients Undergoing Liver Transplantation | July 2013 | November 2017 | |
| NCT01486511 | Unknown status | Pulmonary Embolism After Liver Resection | January 2007 | January 2012 | |
| NCT02541825 | Unknown status | Phase 1 | Using Covered Stent of Diameter of 7mm in TIPS | August 2015 | December 2017 |
| NCT02070315 | Unknown status | Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM | February 2012 | November 2020 | |
| NCT02074202 | Unknown status | Phase 3 | To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma | February 2014 | March 2015 |
| NCT01148277 | Unknown status | N/A | Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-B | August 2011 | February 2012 |
| NCT01169168 | Unknown status | Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU) | April 2010 | ||
| NCT02938871 | Unknown status | N/A | Effect of Synbiotic on Postoperative Complications After Liver Transplantation | March 2016 | January 2018 |
| NCT01643512 | Unknown status | Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members | August 2011 | August 2021 | |
| NCT02420496 | Withdrawn | Phase 2 | Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants | June 2016 | June 2016 |
| NCT02098785 | Withdrawn | Phase 1 | Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study | March 2018 | September 2018 |
| NCT01619449 | Withdrawn | N/A | Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant | April 2012 | December 2014 |
| NCT01547078 | Withdrawn | Phase 2 | Clinical Study of Lyophilized Plasma in Patients With Liver Disease | January 2015 | January 2016 |
| NCT02712775 | Withdrawn | Phase 4 | Minocycline Administration During Human Liver Transplantation | March 2016 | March 2016 |
| NCT01191177 | Withdrawn | Phase 1/Phase 2 | Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease | January 2011 | January 2012 |
- Disase is a (Disease Ontology)
- DOID:3118
- Cross Reference ID (Disease Ontology)
- ICD10CM:K76.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:573.9
- Cross Reference ID (Disease Ontology)
- MESH:D008107
- Cross Reference ID (Disease Ontology)
- NCI:C3196
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:62857009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0023895
- Exact Synonym (Disease Ontology)
- disorder of liver
- Exact Synonym (Disease Ontology)
- hepatic disorder